UBS Group’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Sell |
650,704
-2,455,852
| -79% | -$1.8M | ﹤0.01% | 4875 |
|
|
2025
Q1 | $3.11M | Buy |
3,106,556
+1,864,611
| +150% | +$1.86M | ﹤0.01% | 3365 |
|
|
2024
Q4 | $13.2M | Buy |
1,241,945
+902,274
| +266% | +$9.56M | ﹤0.01% | 2111 |
|
|
2024
Q3 | $4.49M | Buy |
339,671
+44,014
| +15% | +$581K | ﹤0.01% | 2367 |
|
|
2024
Q2 | $2.91M | Buy |
295,657
+270,376
| +1,069% | +$2.66M | ﹤0.01% | 2532 |
|
|
2024
Q1 | $348K | Buy |
25,281
+25,025
| +9,775% | +$344K | ﹤0.01% | 4341 |
|
|
2023
Q4 | $4.37K | Buy |
+256
| New | +$4.37K | ﹤0.01% | 6661 |
|